KFDA approves new anti-impotency drug

Published: 2011-08-19 06:56:00
Updated: 2011-08-19 06:56:00
The Korea Food and Drug Administration (KFDA) yesterday approved the domestic sale of Zepid (avanafil), a new type of anti-impotency drug.

Created by JW Pharmaceutical, Zepid is Korea’s third homegrown erectile dysfunction medicine - Dong-A Pharmaceutical`s Zydena and SK Chemicals’ Mvix.

Av...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.